Onyx exec pay dwarfs profits

Onyx Pharmaceuticals turned a profit for 2008. Lucky for shareholders, even luckier for management. As BNet Pharma reports, the executive team at Onyx saw their pay rise in a big way. In fact, the increase in executive pay was about double Onyx's net income of $1.9 million.

The pay picture isn't exactly cut-and-dried because the company got a new CEO and added an HR chief to the mix. So, the old CEO got $2.5 million for his partial year's service, and the new one--N. Anthony Coles--was paid $2.8 million for his partial year, which began last March. For comparison's sake, the ex-chief was paid $2.6 million for all of 2007. Total CEO pay for 2008: $5.3 million.

CFO Gregory Schafer saw his pay bumped up to $818,000 from $690,000, which COO Laura Brege got a raise to $1.7 million from $1.4 million in 2007. The HR chief added to the exec committee--Judy Batlin--earned $937,000.

- read the BNet item

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.